A pilot randomised controlled trial of omega-3 fatty acid supplements to prevent skin cancer in lung transplant recipients

Phase 2

Completed

• Conditions: Skin Cancer; Lung Transplant; Respiratory - Other respiratory disorders / diseases; Cancer - Non melanoma skin cancer

• Registration Number: ACTRN12614000873628
• Lead Sponsor: QIMR Berghofer Medical Research Institute

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2014-08-14
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

1.Male and female lung transplant recipients Greater than or equal to 18 years of age.
2.Greater than or equal to 1 year post lung transplant.
3.Use of systemic retinoid therapy permitted if on stable dosing for previous 3 months.
4.Will be able to attend the clinic for at least Visit 1 and Visit 4 within the recruitment timeframe.

Exclusion Criteria

1. Unable to give informed consent.
2. Have innately black or dark brown skin.
3. Have a fish allergy.
4. Have a soya allergy.
5. Unable to take gelatin.
6. Have a bleeding disorder or bleeding episode in last 3 months
7. Are receiving warfarin, heparin or low molecular weight heparin in therapeutic doses. (Patients receiving heparin or low molecular weight heparin in prophylactic doses will not be excluded)
8. Are already taking fish oil supplements and unwilling to discontinue for 2 months before randomisation and for trial period.
9. Pregnant

Study & Design

• Study Type: Interventional
• Study Design: Not specified